×
You've used up your 3 free articles for this month. Subscribe today.
D.C. Circuit Grants BOP Medical Director Qualified Immunity in Suit Over Delayed Treatment of Prisoner’s Hepatitis C
by Matt Clarke
On July 5, 2022, the U.S. Court of Appeals for the District of Columbia Circuit held that the medical director of the federal Bureau of Prisons (BOP) was entitled to qualified immunity (QI) in a prisoner’s lawsuit over delayed treatment of his Hepatitis-C with direct-acting antiviral (DAA) ...
Full article and associated cases available to subscribers.
As a digital subscriber to Prison Legal News, you can access full text and downloads for this and other premium content.
Already a subscriber? Login